Table 1

ALDH+ cells in CD19+CD5+ primary MCL cells

Patient no.ALDH+, %
7.85 
0.90 
1.20 
0.40 
Patient no.ALDH+, %
7.85 
0.90 
1.20 
0.40 

Percentage of ALDH+ tumor cells from 4 patients with MCL. Cells were gated according to forward and side scatter followed by CD19+CD5+ coexpression for analysis of tumor cells.

Close Modal

or Create an Account

Close Modal
Close Modal